Pathologic correlation of 18F-16 beta-fluoro-5 alpha-dihydrotestosterone (FDHT) and FDG PET in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC)

Autor:	Feldman, J. L., Fox, J. J., Martinez, D. F., Autio, K. A., Jeremy Durack, Humm, J., Schoder, H., Gavane, S. C., Curtis, K. R., Balakirsky, S. M., Cohen, R. M., Scher, H. I., Larson, S. M., Morris, M. J.
Zdroj:	Memorial Sloan Kettering Cancer Center
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::ddf1350db9b1c434335aa8b198d75d86 https://synapse.mskcc.org/synapse/works/80899 Zobrazit plný text záznamu